Literature DB >> 2155323

Plant antitumor agents. 29. Synthesis and biological activity of ring D and ring E modified analogues of camptothecin.

A W Nicholas1, M C Wani, G Manikumar, M E Wall, K W Kohn, Y Pommier.   

Abstract

The total synthesis of the pentacyclic camptothecin analogues 3 and 4 in 11 steps from p-tolualdehyde is described. The overall shape of compound 3 is the same as that of potent, naturally occurring camptothecin (1a). Despite the near spatial identity of 3 and 1b (racemic, (20RS)-camptothecin) from a three-dimensional standpoint, the 9KB and 9PS cytotoxicity assays indicate at least a 40-60-fold decrease in activity of 3 compared to that of 1b, and the isomer 4 was inactive. Similarly, studies of the inhibition of topoisomerase I activity indicated only slight activity for 3 and no activity for 4. It is evident that the pyridone ring D is essential for antitumor activity. Three E ring modified analogues of camptothecin, 2d-f, are described in which the net change is replacement of O by N in ring E. Compared to (20S)-camptothecin (1a) or (20RS)-camptothecin (1b), the ring E modified analogues 2d-f display little or no cytotoxic activity, greatly reduced effect on the inhibition of topoisomerase I, and total loss of life prolongation in the in vivo L-1210 mouse leukemia assay, indicative of the highly restricted structural and electronic requirements of ring E for biological activity in camptothecin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2155323     DOI: 10.1021/jm00165a014

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  A mechanistic and kinetic study of the E-ring hydrolysis and lactonization of a novel phosphoryloxymethyl prodrug of camptothecin.

Authors:  Bradley A Hanson; Richard L Schowen; Valentino J Stella
Journal:  Pharm Res       Date:  2003-07       Impact factor: 4.200

Review 2.  Camptothecins: a review of their chemotherapeutic potential.

Authors:  Hulya Ulukan; Peter W Swaan
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Structure-Based Drug Design and Identification of H2O-Soluble and Low Toxic Hexacyclic Camptothecin Derivatives with Improved Efficacy in Cancer and Lethal Inflammation Models in Vivo.

Authors:  Peichen Pan; Jiean Chen; Xijian Li; Miyang Li; Huidong Yu; Jean J Zhao; Jing Ni; Xuwen Wang; Huiyong Sun; Sheng Tian; Feng Zhu; Feng Liu; Yong Huang; Tingjun Hou
Journal:  J Med Chem       Date:  2018-09-27       Impact factor: 7.446

Review 4.  Cancer therapies utilizing the camptothecins: a review of the in vivo literature.

Authors:  Vincent J Venditto; Eric E Simanek
Journal:  Mol Pharm       Date:  2010-04-05       Impact factor: 4.939

5.  VLA4-Targeted Nanoparticles Hijack Cell Adhesion-Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival.

Authors:  Francesca Fontana; Michael J Scott; John S Allen; Xiaoxia Yang; Grace Cui; Dipanjan Pan; Noriko Yanaba; Mark A Fiala; Julie O'Neal; Anne H Schmieder-Atteberry; Julie Ritchey; Michael Rettig; Kathleen Simons; Steven Fletcher; Ravi Vij; John F DiPersio; Gregory M Lanza
Journal:  Clin Cancer Res       Date:  2020-12-22       Impact factor: 13.801

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.